Skip to main content

Table 3 Basic result of ICUR and One-way sensitivity analysis for 50% surgery rate

From: Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model

Treatment strategy

Average costs per

Incremental cost

Average Efficacy

Incremental QALYs

ICUR, US$/QALYs

person, $

QALYs

Treatment all by medication

 Positive Treatment

3887.38

 

6.58

  

 Traditional Treatment

1975.79

1911.59

6.43

0.15

12,743.93

50% surgery rate

 Positive Treatment

2703.58

 

6.58

  

 Traditional Treatment

1975.79

727.79

6.43

0.15

4851.93

25% surgery rate

 Positive Treatment

3295.48

 

6.58

  

 Traditional Treatment

1975.79

1319.69

6.43

0.15

8798.93

One-way sensitivity analysis for 50% surgery rate

 Positive Treatment (transfer probability)

  Mild NTG to moderate NTG (+ 50%)

2894.83

 

6.55

  

1975.79

919.04

6.43

0.12

7658.67

  Mild NTG to moderate NTG (-50%)

2487.89

 

6.62

  

1975.79

512.1

6.43

0.19

2695.26

  Moderate NTG to severe NTG (+ 50%)

2703.62

 

6.58

  

1975.79

727.83

6.43

0.15

4852.20

  Moderate NTG to severe NTG (-50%)

2703.53

 

6.58

  

1975.79

727.74

6.43

0.15

4851.60

Cost input for Positive Treatment

 Cost of eye drops (+ 20%)

3073.11

 

6.58

  

1975.79

1097.32

6.43

0.15

7315.47

 Cost of eye drops (-20%)

2334.04

 

6.58

  

1975.79

358.25

6.43

0.15

2388.33

 Cost of trabeculectomy (+ 20%)

2730.12

 

6.58

  

1975.79

754.33

6.43

0.15

5028.87

 Cost of trabeculectomy (-20%)

2677.03

 

6.58

  

1975.79

701.24

6.43

0.15

4674.93

 Follow-up (+ 20%)

2848.21

 

6.58

  

2144.06

704.15

6.43

0.15

4694.33

 Follow-up (-20%)

2558.94

 

6.58

  

1807.53

751.41

6.43

0.15

5009.40

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us